EcoDrugPlus

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSBSLG00000002039
Gene Symbol: F2R
3 Cross references
211 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSBSLG00000004226
Gene Symbol: F3
3 Cross references
199 Possible Orthologues:

Coagulation Factor Vii-Like

Ensembl ID : ENSBSLG00000001423
Gene Symbol: LOC114848295
3 Cross references
203 Possible Orthologues:

Coagulation Factor Xi-Like

Ensembl ID : ENSBSLG00000005105
Gene Symbol: LOC114865983
2 Cross references
203 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSBSLG00000018777
Gene Symbol: CCDC6
3 Cross references
208 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSBSLG00000016273
Gene Symbol: LOC114869183
2 Cross references
303 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSBSLG00000017971
Gene Symbol: CSF1R
3 Cross references
207 Possible Orthologues:

Complement C5

Ensembl ID : ENSBSLG00000002668
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSBSLG00000018322
Gene Symbol: CRHR1
2 Cross references
208 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSBSLG00000002723
Gene Symbol: CCND1
3 Cross references
232 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSBSLG00000019295
Gene Symbol: CDK1
3 Cross references
246 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSBSLG00000001470
Gene Symbol: CDK2
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).